{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:30:49Z","timestamp":1787333449520,"version":"build-2736575974"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"DOI":"10.1007\/s10620-026-10191-6","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:01:38Z","timestamp":1787331698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Inflammatory Bowel Disease in Women and the Fertility Marker Anti-M\u00fcllerian Hormone"],"prefix":"10.1007","author":[{"given":"Inas","family":"Mikhail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Odah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana G.","family":"Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Kuohung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A.","family":"Farraye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"10191_CR1","unstructured":"National Health Statistics Reports, 2024. Infertility and impaired fecundity in women and men in the United States, 2015\/20"},{"key":"10191_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1093\/ibd\/izz092.","volume":"25","author":"K Keyashian","year":"2019","unstructured":"Keyashian K, Dehghan M, Sceats L et al. Comparative incidence of inflammatory bowel disease in different age groups in the United States. Inflamm Bowel Dis. 2019;25:1983\u20131989. https:\/\/doi.org\/10.1093\/ibd\/izz092.","journal-title":"Inflamm Bowel Dis."},{"key":"10191_CR3","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513.","volume":"105","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LME, Visser JA. Anti-M\u00fcllerian hormone and ovarian reserve: update on assessing ovarian function. J Clin Endocrinol Metab. 2020;105:3361\u20133373. https:\/\/doi.org\/10.1210\/clinem\/dgaa513.","journal-title":"J Clin Endocrinol Metab."},{"key":"10191_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.fertnstert.2018.02.085","volume":"109","author":"P Rekawek","year":"2018","unstructured":"Rekawek P et al. Ovarian reserve is not compromised in patients with inflammatory bowel disease. Fertil Steril 2018;109:43\u201344.","journal-title":"Fertil Steril"},{"key":"10191_CR5","first-page":"101","volume":"12","author":"J Martin","year":"2016","unstructured":"Martin J, Kane SV, Feagins LA. Fertility and contraception in women with inflammatory bowel disease. Gastroenterol Hepatol. 2016;12:101.","journal-title":"Gastroenterol Hepatol."},{"key":"10191_CR6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033113.","volume":"102","author":"L Guo","year":"2023","unstructured":"Guo L, Liu Y, Li J, Liu Q, Liu B, Shi X. Inflammatory bowel disease can reduce ovarian reserve function in women: a systematic review and meta-analysis. Medicine (Baltimore). 2023;102:e33113. https:\/\/doi.org\/10.1097\/MD.0000000000033113.","journal-title":"Medicine (Baltimore)."},{"key":"10191_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101517.","volume":"1","author":"H Sun","year":"2022","unstructured":"Sun H, Jiao J, Tian F, Liu Q, Bian J, Xu R, Li D, Wang X, Shu H. Ovarian reserve and IVF outcomes in patients with inflammatory bowel disease: A systematic review and meta-analysis. EClinicalMedicine. 2022;1:101517. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101517.","journal-title":"EClinicalMedicine."},{"key":"10191_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/09513590.2019.1684465.","volume":"36","author":"C Hernandez-Nieto","year":"2020","unstructured":"Hernandez-Nieto C, Sekhon L, Lee J, Gounko D, Copperman A, Sandler B. Infertile patients with inflammatory bowel disease have comparable in vitro fertilization clinical outcomes to the general infertile population. Gynecol Endocrinol. 2020;36:554\u2013557. https:\/\/doi.org\/10.1080\/09513590.2019.1684465.","journal-title":"Gynecol Endocrinol."},{"key":"10191_CR9","doi-asserted-by":"publisher","first-page":"1417896","DOI":"10.3389\/fendo.2024.1417896.","volume":"9","author":"Y Du","year":"2024","unstructured":"Du Y, Hu Y, Sheng Y, Zhu T, Liu S, Ding H, Guan Y. Primary ovarian insufficiency consequence of autoimmune diseases: a bidirectional two-sample Mendelian randomization study. Front Endocrinol (Lausanne). 2024;9:1417896. https:\/\/doi.org\/10.3389\/fendo.2024.1417896.","journal-title":"Front Endocrinol (Lausanne)."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10191-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10191-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10191-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:01:43Z","timestamp":1787331703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10191-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":9,"alternative-id":["10191"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10191-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"IM, TO, JF, and WK: No disclosures. JGH: Consulting Fee: BMS. FAF: Consulting Fee: Astellas, Avalo Therapeutics, Bausch, Biocon, Braintree Labs, Celltrion, Cristcot,\u00a0GI Reviewers, IBD Educational Group, Iterative Health, Janssen, Moderna, Merck, Metaphore Biotechnologies, and Pfizer. DSMB: Eli Lilly and Moonlake Immunotherapeutics.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}